HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Broncus Holding Corporation - The Strength and the Concerns

Pre-IPO Hangzhou Bioer Technology - Concerns Behind the Outstanding Performance

Pre-IPO Abbisko Cayman - It Still Takes Some Time for Commercialization

Presentation on Apr.12: 2021 High Conviction Ideas - Topchoice Medical (600763.CH)

Pre-IPO Chaoju Eye Care Holdings - Here Are the Strength and the Concerns

Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Capital Markets

Clarity Medical Group / Equity Capital Markets

<p>With the aging of the population and the increasing pressure of work, various eye diseases such as cataract, glaucoma, astigmatism, myopia emerge. Fortunately, with the continuous improvement of medical technology and medical system, in addition to public ophthalmic hospitals, private ophthalmic hospitals are also rising. On May 7<sup>th</sup>, 2021, <a href="https://www.smartkarma.com/entities/clarity-medical-group" target="_blank" data-smartkarma-citation="entities:28042:1" rel="noopener">Clarity Medical Group (CMG HK)</a> filed a prospectus with the Hong Kong Stock Exchange to apply for its main board listing. In fact, Clarity was ready to go public in 2019 but failed. However, after two years, the prospects for the IPO are not necessarily brighter.</p>

With the aging of the population and the increasing pressure of work, various eye diseases such as cataract, glaucoma, astigmatism, myopia emerge. Fortunately, with the continuous improvement of medical technology and medical system, in addition to public ophthalmic hospitals, private ophthalmic hospitals are also rising. On May 7th, 2021, Clarity Medical Group (CMG HK) filed a prospectus with the Hong Kong Stock Exchange to apply for its main board listing. In fact, Clarity was ready to go public in 2019 but failed. However, after two years, the prospects for the IPO are not necessarily brighter.

Pre-IPO Clarity Medical Group - The Prospects Are Still Not Brighter